121 related articles for article (PubMed ID: 1973006)
1. Internalization of recombinant tissue-type plasminogen activator by isolated rat hepatocytes is via coated pits.
Marks GJ; Hart TK; Rush GF; Hoffstein ST; Fong KL; Bugelski PJ
Thromb Haemost; 1990 Apr; 63(2):251-8. PubMed ID: 1973006
[TBL] [Abstract][Full Text] [Related]
2. Modulation of intracellular potassium and ATP: effects on coated pit function in fibroblasts and hepatocytes.
Larkin JM; Donzell WC; Anderson RG
J Cell Physiol; 1985 Sep; 124(3):372-8. PubMed ID: 2864349
[TBL] [Abstract][Full Text] [Related]
3. The role of the low-density lipoprotein receptor-related protein (LRP) in the plasma clearance and liver uptake of recombinant single-chain urokinase-type plasminogen activator in rats.
van der Kaaden ME; Rijken DC; Kruijt JK; van Berkel TJ; Kuiper J
Thromb Haemost; 1997 Apr; 77(4):710-7. PubMed ID: 9134648
[TBL] [Abstract][Full Text] [Related]
4. Endocytosis of the recombinant tissue plasminogen activator alteplase by hepatic endothelial cells.
Seydel W; Stang E; Roos N; Krause J
Arzneimittelforschung; 1991 Feb; 41(2):182-6. PubMed ID: 1904231
[TBL] [Abstract][Full Text] [Related]
5. Cluster mannosides can inhibit mannose receptor-mediated tissue-type plasminogen activator degradation by both rat and human cells.
Noorman F; Barrett-Bergshoeff MM; Biessen EA; van de Bilt E; van Berkel TJ; Rijken DC
Hepatology; 1997 Nov; 26(5):1303-10. PubMed ID: 9362376
[TBL] [Abstract][Full Text] [Related]
6. Characterization of the interaction of a complex of tissue-type plasminogen activator and plasminogen activator inhibitor type 1 with rat liver cells.
Kuiper J; Otter M; Voorschuur AH; van Zonneveld AJ; Rijken DC; van Berkel TJ
Thromb Haemost; 1995 Nov; 74(5):1298-304. PubMed ID: 8607113
[TBL] [Abstract][Full Text] [Related]
7. Characterization of two distinct pathways of endocytosis of ricin by rat liver endothelial cells.
Magnusson S; Kjeken R; Berg T
Exp Cell Res; 1993 Mar; 205(1):118-25. PubMed ID: 8453986
[TBL] [Abstract][Full Text] [Related]
8. Platelet-derived growth factor: morphologic and biochemical studies of binding, internalization, and degradation.
Rosenfeld ME; Bowen-Pope DF; Ross R
J Cell Physiol; 1984 Nov; 121(2):263-74. PubMed ID: 6092390
[TBL] [Abstract][Full Text] [Related]
9. Multiple pathways for ligand internalization in rat hepatocytes. II: Effect of hyperosmolarity and contribution of fluid-phase endocytosis.
Moss AL; Ward WF
J Cell Physiol; 1991 Nov; 149(2):319-23. PubMed ID: 1721074
[TBL] [Abstract][Full Text] [Related]
10. Plasminogen activator inhibitor 1 contains a cryptic high affinity receptor binding site that is exposed upon complex formation with tissue-type plasminogen activator.
Horn IR; van den Berg BM; Moestrup SK; Pannekoek H; van Zonneveld AJ
Thromb Haemost; 1998 Nov; 80(5):822-8. PubMed ID: 9843178
[TBL] [Abstract][Full Text] [Related]
11. Binding of tissue plasminogen activator to cultured human fibroblasts.
Reilly TM; Whitfield MD; Taylor DS; Timmermans PB
Thromb Haemost; 1989 Jun; 61(3):454-8. PubMed ID: 2552605
[TBL] [Abstract][Full Text] [Related]
12. Potassium depletion and hypertonic medium reduce "non-coated" and clathrin-coated pit formation, as well as endocytosis through these two gates.
Carpentier JL; Sawano F; Geiger D; Gorden P; Perrelet A; Orci L
J Cell Physiol; 1989 Mar; 138(3):519-26. PubMed ID: 2466853
[TBL] [Abstract][Full Text] [Related]
13. Differences between fluid-phase endocytosis (pinocytosis) and receptor-mediated endocytosis in isolated rat hepatocytes.
Strømhaug PE; Berg TO; Gjøen T; Seglen PO
Eur J Cell Biol; 1997 May; 73(1):28-39. PubMed ID: 9174669
[TBL] [Abstract][Full Text] [Related]
14. Native and non-glycosylated recombinant single-chain urokinase-type plasminogen activator are recognized by different receptor systems on rat parenchymal liver cells.
van der Kaaden ME; Rijken DC; Groeneveld E; van Berkel TJ; Kuiper J
Thromb Haemost; 1995 Aug; 74(2):722-9. PubMed ID: 8585013
[TBL] [Abstract][Full Text] [Related]
15. Thrombomodulin lacking the cytoplasmic domain efficiently internalizes thrombin via nonclathrin-coated, pit-mediated endocytosis.
Conway EM; Nowakowski B; Steiner-Mosonyi M
J Cell Physiol; 1994 Feb; 158(2):285-98. PubMed ID: 8106566
[TBL] [Abstract][Full Text] [Related]
16. Nonlinear pharmacokinetics of tissue-type plasminogen activator in three animal species and isolated perfused rat liver.
Tanswell P; Heinzel G; Greischel A; Krause J
J Pharmacol Exp Ther; 1990 Oct; 255(1):318-24. PubMed ID: 2120422
[TBL] [Abstract][Full Text] [Related]
17. Receptor-bound thrombin is not internalized through coated pits in mouse embryo cells.
Bergmann JS; Carney DH
J Cell Biochem; 1982; 20(3):247-58. PubMed ID: 6132925
[TBL] [Abstract][Full Text] [Related]
18. Clearance of tissue plasminogen activator by mannose and galactose receptors in the liver.
Smedsrød B; Einarsson M
Thromb Haemost; 1990 Feb; 63(1):60-6. PubMed ID: 2160132
[TBL] [Abstract][Full Text] [Related]
19. Expression of tissue-type plasminogen activator and its inhibitor couples with development of capillary network by human microvascular endothelial cells on Matrigel.
Ito K; Ryuto M; Ushiro S; Ono M; Sugenoya A; Kuraoka A; Shibata Y; Kuwano M
J Cell Physiol; 1995 Feb; 162(2):213-24. PubMed ID: 7822431
[TBL] [Abstract][Full Text] [Related]
20. Binding and degradation of tissue-type plasminogen activator by the human hepatoma cell line Hep G2.
Otter M; Van Berkel TJ; Rijken DC
Thromb Haemost; 1989 Sep; 62(2):667-72. PubMed ID: 2510347
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
